Carregant...
IL-33 in Tumor Immunity: Nothing to Sneeze At
Although immunotherapy has been at the forefront of cancer therapy for the last several years, better clinical responses are still desired. Interleukin-33 is perhaps one of the most overlooked antitumor cytokines. Its ability to promote type 1 immune responses, winch control tumor growth in preclini...
Guardat en:
| Publicat a: | Crit Rev Immunol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087446/ https://ncbi.nlm.nih.gov/pubmed/31002600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1615/CritRevImmunol.2018026335 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|